• Involvement of activating ERK1/2 through G protein coupled receptor 30 and estrogen receptor α/β in low doses of bisphenol A promoting growth of Sertoli TM4 cells
  Catalog No.:BS4621        Pubmed No.:24495410        PMCID:
  Details:
  Journal name:
• Involvement of activating ERK1/2 through G protein coupled receptor 30 and estrogen receptor α/β in low doses of bisphenol A promoting growth of Sertoli TM4 cells
  Catalog No.:BS1741        Pubmed No.:24495410        PMCID:
  Details:
  Journal name:
• Akt Mediates GSK-3β Phosphorylation in the Rat Prefrontal Cortex during the Process of Ketamine Exerting Rapid Antidepressant Actions
  Catalog No.:BS1402        Pubmed No.:24504086        PMCID:
  Details:
  Journal name:
• Akt Mediates GSK-3β Phosphorylation in the Rat Prefrontal Cortex during the Process of Ketamine Exerting Rapid Antidepressant Actions
  Catalog No.:BS4084        Pubmed No.:24504086        PMCID:
  Details:
  Journal name:
• Akt Mediates GSK-3β Phosphorylation in the Rat Prefrontal Cortex during the Process of Ketamine Exerting Rapid Antidepressant Actions
  Catalog No.:BS3611        Pubmed No.:24504086        PMCID:
  Details:
  Journal name:
• Akt Mediates GSK-3β Phosphorylation in the Rat Prefrontal Cortex during the Process of Ketamine Exerting Rapid Antidepressant Actions
  Catalog No.:BS4706        Pubmed No.:24504086        PMCID:
  Details:
  Journal name:
• The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK-and MAPK-dependent mechanisms
  Catalog No.:BS1010        Pubmed No.:24490809        PMCID:
  Details:
  Journal name:
• The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK-and MAPK-dependent mechanisms
  Catalog No.:BS4010        Pubmed No.:24490809        PMCID:
  Details:
  Journal name:
• The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK-and MAPK-dependent mechanisms
  Catalog No.:BS1810        Pubmed No.:24490809        PMCID:
  Details:
  Journal name:
• The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK-and MAPK-dependent mechanisms
  Catalog No.:BS4007        Pubmed No.:24490809        PMCID:
  Details:
  Journal name:
• The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK-and MAPK-dependent mechanisms
  Catalog No.:AP0486        Pubmed No.:24490809        PMCID:
  Details:
  Journal name:
• The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK-and MAPK-dependent mechanisms
  Catalog No.:AP0424        Pubmed No.:24490809        PMCID:
  Details:
  Journal name:
• The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK-and MAPK-dependent mechanisms
  Catalog No.:BS4635        Pubmed No.:24490809        PMCID:
  Details:
  Journal name:
• The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK-and MAPK-dependent mechanisms
  Catalog No.:BS4766        Pubmed No.:24490809        PMCID:
  Details:
  Journal name:
• The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK-and MAPK-dependent mechanisms
  Catalog No.:BS3627        Pubmed No.:24490809        PMCID:
  Details:
  Journal name: